RxDoctor Payments Data

Glen Lilly, PA

Physician Assistant · Hollywood, MDNPI 1275935934

Payments from drug & device makers

$1,954in general payments, 2019–2025

Across 104 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$400
  • AbbVie$275
  • Lilly USA, LLC$216
  • AstraZeneca$167
  • Bayer$100
  • Exact Sciences$83
  • plus $713 from 18 others

What the payments were for

  • Food & beverage$1,954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,954 in reported general payments places this provider in the 85th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$96,974
Medicare patients
410
Services billed
1,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$125,002
FarxigaDapagliflozin Propanediol39$44,372
EliquisApixaban26$36,839
TrulicityDulaglutide18$31,140
JardianceEmpagliflozin14$23,304
Tresiba Flextouch U-200Insulin Degludec19$18,285
JanuviaSitagliptin Phosphate11$18,104
Bydureon BciseExenatide Microspheres11$17,125
Tresiba Flextouch U-100Insulin Degludec21$16,205
Breo ElliptaFluticasone/Vilanterol11$8,028
TrintellixVortioxetine Hydrobromide12$5,667
Atorvastatin Calcium515$4,568
Esomeprazole Magnesium15$2,686
Rosuvastatin Calcium180$2,685
Wixela InhubFluticasone Propion/Salmeterol15$2,570

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$400$125,00291 claims
AstraZenecaFarxiga$167$44,37239 claims
PfizerEliquis$53$36,83926 claims
Lilly USA, LLCTrulicity$216$31,14018 claims
MerckJanuvia$36$18,10411 claims
GSKBreo Ellipta$39$8,02811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Hollywood

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →